Authors: Vilma Joseph, MD, MPH, FASA et al ASA Monitor May 2024, Vol. 88, 33–35. In 2009, the ASA Committee on Professional Diversity (CPD) created the ASA Mentoring Grant. The CPD was chaired by Gregory Kerr, MD, MBA, and the inaugural director of the grant program was Karen Williams, MD. This grant was intended to foster […]
Read MoreASA Monitor May 2024, Vol. 88, 25. For which of the following local anesthetics is the duration of action MOST prolonged by the addition of epinephrine? (A) Bupivacaine (B) Lidocaine (C) Etidocaine Vasoconstrictors are added to local anesthetic solutions to decrease the rate of vascular absorption of local anesthetic deposited near the nerve. The added vasoconstrictor […]
Read MoreAuthors: Giacomo F. Scorsese, DO Jacob Nouriel, MD ASA Monitor May 2024, Vol. 88, 34–35. In general, the practice of anesthesiology and implementation of anesthetics have changed significantly since the days of the copper kettle and drop ether. Notable milestones in the 20th century included halogenated volatile anesthetics, intravenous induction drugs, carbon dioxide absorbents, continuous […]
Read MoreAuthors: Seyed A. Safavynia, MD, PhD; Shobana Rajan, MD, FASA ASA Monitor May 2024, Vol. 88, 28–29. Electroencephalographic (EEG) monitoring has become increasingly commonplace in the anesthesiologist’s practice since the Bispectral IndexTM (BISTM) Monitor (Medtronic) was approved by the U.S. Food and Drug Administration (FDA) in 1996 for monitoring anesthetic depth. Today, several other intraoperative EEG devices exist, […]
Read MoreAuthor: Kayla M. Knuf, MD ASA Monitor May 2024, Vol. 88, 26. Perioperative mortality is most often defined as the rate of death following surgery and anesthesia beginning on the day of surgery and extending to the 30th postoperative day or the day of discharge from the hospital (BR J Anaesth 2015;114:32-42). While this seems to be […]
Read MoreASA Monitor May 2024, Vol. 88, 27. AstraZeneca has announced the availability of its inhaled, fixed-dose combination rescue medication Airsupra® (albuterol/budesonide) in the U.S. by prescription, following FDA approval in January 2023. Airsupra is indicated for the as-needed treatment or prevention of asthma symptoms and to prevent sudden severe breathing problems, such as asthma attacks, in adults […]
Read MoreAuthors: George Tewfik, MD, MBA, FASA; Raymond Malapero, MD, MPH, FASA ASA Monitor May 2024, Vol. 88, e2–e3. If you have worked in any health care system, you have almost certainly heard these phrases uttered during your work experience: “That’s how it’s always been done.” “That’s what the surgeon likes.” “But your colleagues do it that way.” […]
Read MoreASA Monitor May 2024, Vol. 88, 12. A 61 y/o male was admitted with acute onset of stroke. Neuroradiologic imaging confirmed a thrombotic etiology, and alteplase was administered. The patient was emergently brought to an interventional suite for definitive treatment. He was intubated by the anesthesia team consisting of an attending anesthesiologist and a CRNA. The […]
Read MoreASA Monitor May 2024, Vol. 88, 27. Researchers at the National Institutes of Health (NIH) investigated the immune system responses and microbiome changes in individuals who switched between a vegan and ketogenic (keto) diet over two-week periods. They found that the vegan diet stimulated innate immunity, while the keto diet triggered adaptive immune responses. The study […]
Read MoreASA Monitor May 2024, Vol. 88, 27. The CEREGLIDE™ 71 Intermediate Catheter with TruCourse™ from Cerenovus, Inc., a division of Johnson & Johnson MedTech, is now available in the United States. The catheter is designed for the revascularization of acute ischemic stroke patients and facilitates direct aspiration and compatible stent retriever delivery, aiding in restoring blood […]
Read More